PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
56.59%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
-12.93%
Cost reduction while VET shows 137.07% growth. Joel Greenblatt would examine competitive advantage.
169.31%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
71.99%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-8.82%
G&A reduction while VET shows 140.89% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
13.33%
Other expenses change of 13.33% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
9.35%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
-2.41%
Total costs reduction while VET shows 8.95% growth. Joel Greenblatt would examine advantage.
3.08%
Interest expense growth 50-75% of VET's 5.91%. Bruce Berkowitz would examine efficiency.
-1.55%
Both companies reducing D&A. Martin Whitman would check industry patterns.
208.30%
EBITDA growth while VET declines. John Neff would investigate advantages.
102.93%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
346.02%
Operating income growth while VET declines. John Neff would investigate advantages.
257.12%
Operating margin growth while VET declines. John Neff would investigate advantages.
58.72%
Other expenses growth less than half of VET's 209.67%. David Dodd would verify if advantage is sustainable.
86.38%
Pre-tax income growth exceeding 1.5x VET's 2.12%. David Dodd would verify competitive advantages.
91.30%
Pre-tax margin growth exceeding 1.5x VET's 20.58%. David Dodd would verify competitive advantages.
71.06%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
93.57%
Net income growth 1.25-1.5x VET's 84.80%. Bruce Berkowitz would examine sustainability.
95.89%
Similar net margin growth to VET's 118.20%. Walter Schloss would investigate industry trends.
93.61%
EPS growth 1.25-1.5x VET's 83.87%. Bruce Berkowitz would examine sustainability.
93.61%
Diluted EPS growth 1.25-1.5x VET's 80.65%. Bruce Berkowitz would examine sustainability.
0.03%
Share count reduction exceeding 1.5x VET's 0.79%. David Dodd would verify capital allocation.
No Data
No Data available this quarter, please select a different quarter.